Posted On: 04/29/2015 9:03:12 AM
Post# of 377
$PPCH We should see the beginning of a reversal here soon, commencing the next leg up of an uptrend. RSI and accum/dist appear oversold. We tapped the 200MA yesterday but it held as support at .027 with a close at .03. Provided support holds at .027 and does not break the 200 day in favor of turning .0225(50MA) into support, we should be about ready. As long as .0225 remains as support, I see nothing abnormal here. RSI is sitting at 47.32. The last time the RSI was under 50 was around the 9th of March in which we ran from .00's to the .05 range before downtrending into the corrective phase of the wave. We then held high .01's as support before running to .10. That takes us into the current correction. Each time, support has been higher as have the resistance levels. I'm looking to see us break .10 and hold for at least a small window of time before turning the .05-.07 range as new support on the downtrend following our near-term run. We need to hit the .15-.25 area for the aforementioned to hold water.
From a fundamental perspective, we have a lot going on. We have a series of near and mid-term catalysts, such as the results of the animal studies and the investors' conference on the 28th of May. We have also received 1M in private funding not to mention the five page NY Times write-up introduced and prefaced by Cancer Treatment Centers.
This is also a great investment from a humanitarian perspective. Take a look at cancer statistics and survival rates. Look closely into what it means to be a survivor. One is said to be considered cured of colorectal cancer after 5yrs. What is not mentioned is that, if that same person dies of liver cancer, they are still noted as a survivor of colon cancer. What is the cause? Metastasis. The cancer has spread. This is where Propanc comes in. Rather than gamble to see if chemo will kill the cancer cells or healthy cells first, the company is working on a non-toxic treatment using pro-enzyme technology. For more background on enzymes and cancer, look up Dr. Kelly DDS. Dr Kelly cured himself of pancreatic cancer using proteolytic pancreatic enzymes. Also look up biochemist Ernest Krebs and the use of B-17/amygdalin/nitrilosides along with the enzymes. There are more pieces to the cancer puzzle as far as true eradication is concerned but even if this is not the universal cure, if true as a working model, this has potential to save lives and to buy time while advancements proceed. Like computational technologies and Moore's law as referenced in the exponential increase in semiconductor technology, medicine should follow the same suit, riding off of the backs of the tech movement until we reach a point of escape velocity.
Thank you to all holding long here and for contributing for such a great series of runs here. May this be a great investment for all here and to everyone who has been or will be affected by any form of degenerative illness that may be potentially treatable with Propanc's technology.
From a fundamental perspective, we have a lot going on. We have a series of near and mid-term catalysts, such as the results of the animal studies and the investors' conference on the 28th of May. We have also received 1M in private funding not to mention the five page NY Times write-up introduced and prefaced by Cancer Treatment Centers.
This is also a great investment from a humanitarian perspective. Take a look at cancer statistics and survival rates. Look closely into what it means to be a survivor. One is said to be considered cured of colorectal cancer after 5yrs. What is not mentioned is that, if that same person dies of liver cancer, they are still noted as a survivor of colon cancer. What is the cause? Metastasis. The cancer has spread. This is where Propanc comes in. Rather than gamble to see if chemo will kill the cancer cells or healthy cells first, the company is working on a non-toxic treatment using pro-enzyme technology. For more background on enzymes and cancer, look up Dr. Kelly DDS. Dr Kelly cured himself of pancreatic cancer using proteolytic pancreatic enzymes. Also look up biochemist Ernest Krebs and the use of B-17/amygdalin/nitrilosides along with the enzymes. There are more pieces to the cancer puzzle as far as true eradication is concerned but even if this is not the universal cure, if true as a working model, this has potential to save lives and to buy time while advancements proceed. Like computational technologies and Moore's law as referenced in the exponential increase in semiconductor technology, medicine should follow the same suit, riding off of the backs of the tech movement until we reach a point of escape velocity.
Thank you to all holding long here and for contributing for such a great series of runs here. May this be a great investment for all here and to everyone who has been or will be affected by any form of degenerative illness that may be potentially treatable with Propanc's technology.
(0)
(0)
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼
